Marco Orecchioni talks about being awarded the prestigious NIH Director’s New Innovator Award by the National Cancer Institute for his project, “Harnessing Myeloid Olfactory Receptors to Reprogram Tumor Immunity."
@immunologyau.bsky.socialExplore
@immunologyau.bsky.social